Fleming DR - Search Results

1

The safety of injecting insulin through clothing.

Fleming DR, Jacober SJ, Vandenberg MA, Fitzgerald JT, Grunberger G. Fleming DR, et al. Diabetes Care. 1997 Mar;20(3):244-7. doi: 10.2337/diacare.20.3.244. Diabetes Care. 1997. PMID: 9051365 Clinical Trial.

2

Challenging traditional insulin injection practices.

Fleming DR. Fleming DR. Am J Nurs. 1999 Feb;99(2):72-4. Am J Nurs. 1999. PMID: 10036577 No abstract available.

3

Saxagliptin add-on therapy to insulin with or without metformin for type 2 diabetes mellitus: 52-week safety and efficacy.

Barnett AH, Charbonnel B, Li J, Donovan M, Fleming D, Iqbal N. Barnett AH, et al. Clin Drug Investig. 2013 Oct;33(10):707-17. doi: 10.1007/s40261-013-0107-8. Clin Drug Investig. 2013. PMID: 23949898 Clinical Trial.

4

Long-term 4-year safety of saxagliptin in drug-naive and metformin-treated patients with Type 2 diabetes.

Rosenstock J, Gross JL, Aguilar-Salinas C, Hissa M, Berglind N, Ravichandran S, Fleming D. Rosenstock J, et al. Diabet Med. 2013 Dec;30(12):1472-6. doi: 10.1111/dme.12267. Epub 2013 Jul 19. Diabet Med. 2013. PMID: 23802840 Clinical Trial.

5

Comparison of intramuscular versus subcutaneous erythropoietin for the treatment of anemia in CAPD patients.

Abreo K, Lubom JA, Collier L, Fleming D, Work J. Abreo K, et al. Adv Perit Dial. 1994;10:124-8. Adv Perit Dial. 1994. PMID: 7999809 Clinical Trial.

6

Efficacy and safety of saxagliptin combination therapy in US patients with type 2 diabetes.

Karyekar C, Donovan M, Allen E, Fleming D, Ravichandran S, Chen R. Karyekar C, et al. Postgrad Med. 2011 Jul;123(4):63-70. doi: 10.3810/pgm.2011.07.2305. Postgrad Med. 2011. PMID: 21680990 Clinical Trial.

7

Tolerability and efficacy of glycemic control with saxagliptin in older patients (aged ≥ 65 years) with inadequately controlled type 2 diabetes mellitus.

Karyekar CS, Ravichandran S, Allen E, Fleming D, Frederich R. Karyekar CS, et al. Clin Interv Aging. 2013;8:419-30. doi: 10.2147/CIA.S41246. Epub 2013 Apr 16. Clin Interv Aging. 2013. PMID: 23626461 Free PMC article. Clinical Trial.

8

The efficacy and safety of the dipeptidyl peptidase-4 inhibitor saxagliptin in treatment-naïve patients with type 2 diabetes mellitus: a randomized controlled trial.

Frederich R, McNeill R, Berglind N, Fleming D, Chen R. Frederich R, et al. Diabetol Metab Syndr. 2012 Jul 24;4(1):36. doi: 10.1186/1758-5996-4-36. Diabetol Metab Syndr. 2012. PMID: 22828124 Free PMC article.

9

Mightier than the syringe.

Fleming DR. Fleming DR. Am J Nurs. 2000 Nov;100(11):44-8. Am J Nurs. 2000. PMID: 11103635 Review. No abstract available.

10

Effect of saxagliptin as add-on therapy in patients with poorly controlled type 2 diabetes on insulin alone or insulin combined with metformin.

Barnett AH, Charbonnel B, Donovan M, Fleming D, Chen R. Barnett AH, et al. Curr Med Res Opin. 2012 Apr;28(4):513-23. doi: 10.1185/03007995.2012.665046. Epub 2012 Mar 1. Curr Med Res Opin. 2012. PMID: 22313154 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters